Modelling for cost-effectiveness analysis
- 13 December 1999
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 18 (23) , 3235-3244
- https://doi.org/10.1002/(sici)1097-0258(19991215)18:23<3235::aid-sim313>3.0.co;2-6
Abstract
A model creates the framework for a cost‐effectiveness analysis, allowing decision makers to explore the implications of using an intervention in different ways and under different conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the factors that influence costs and effects. This paper considers three aspects of modelling: validating effectiveness estimates; modelling costs; and the implications of common statistical forms. Validation procedures similar to those for effectiveness estimates are proposed for costs. Modellers need to pay more attention to ensuring that the pathway of events described by a model represents costs as well as it does effects. Modellers can also help improve the epidemiological and clinical research on which cost‐effectiveness analyses depend by showing the implications for resource allocation of the statistical forms conventionally used in these fields. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgeryPublished by Elsevier ,2004
- Validating Literature-based Models with Direct Clinical Trial ResultsMedical Decision Making, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence.American Journal of Public Health, 1991
- Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart DiseasePublished by American Medical Association (AMA) ,1991
- Risk ratios and risk differences in estimating the effect of risk factors for cardiovascular disease in the elderlyJournal of Clinical Epidemiology, 1990
- Estimating the benefits of cholesterol lowering: Are risk factors for coronary heart disease multiplicative?Journal of Clinical Epidemiology, 1990
- Economic Analysis of a New Drug: Potential Savings in Hospital Operating Costs from the Use of a Once-Daily Regimen of a Parenteral CephalosporinClinical Infectious Diseases, 1984
- Care of Patients with a Low Probability of Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- ECONOMIC CONSIDERATIONS IN THE MANAGEMENT OF MILD HYPERTENSIONAnnals of the New York Academy of Sciences, 1978